IP Library Granted Patent US 9,840,562
Granted Patent B2
US 9,840,562 · App. 14/692,948 · Granted Dec 12, 2017

Binding molecules to the human OX40 receptor

Inventors: Jing Min (Chesterfield, MO); Yanli Wu (Ballwin, MO); Rory F. Finn (Manchester, MO); Barrett R. Thiele (Saint Louis, MO); Wei Liao (Chesterfield, MO); Ronald P. Gladue (Stonington, CT); Arvind Rajpal (San Francisco, CA); Timothy J. Paradis (Richmond, RI); Peter Brams (Sacramento, CA); Brigitte Devaux (Palo Alto, CA); Yi Wu (Milpitas, CA); Kristopher Toy (San Jose, CA); Heidi N. LeBlanc (Mountain View, CA); Haichun Huang (Fremont, CA)
Assignees: Bristol-Myers Squibb Company; Pfizer Inc.
C07K16/2878A61K2039/505C07K2317/14C07K2317/21C07K2317/565C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,840,562
App. No.
14/692,948
Granted
Dec 12, 2017
Kind
B2
Abstract

The present disclosure provides isolated binding molecules that bind to the human OX40R, nucleic acid molecules encoding an amino acid sequence of the binding molecules, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of making the binding molecules, pharmaceutical compositions containing the binding molecules, and methods of using the binding molecules or compositions.

Claims (38)

1. An isolated nucleic acid molecule comprising a nucleic acid sequence that encodes a binding molecule that competes for binding to human OX40R with an antibody that comprises:

(a) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 7; and

(b) a light chain variable region comprising amino acid sequence of SEQ ID NO: 8.

2. A vector comprising the nucleic acid molecule of claim 1 .

3. The vector according to claim 2 , further comprising an expression control sequence operably linked to the nucleic acid molecule.

4. A recombinant host cell comprising the vector according to claim 2 .

5. A method for producing a monoclonal antibody or an antigen-binding fragment thereof that specifically binds human OX40R, comprising culturing the isolated host cell of claim 4 under suitable conditions and recovering said antibody or fragment.

6. An isolated nucleic acid molecule comprising a nucleic acid sequence that encodes a heavy chain or an antigen-binding fragment thereof, and a light chain or an antigen-binding fragment thereof of an antibody that specifically binds human OX40R, wherein said antibody comprises:

(a) a heavy chain variable region (V H ) comprising V H CDR1, V H CDR2 and V H CDR3 regions that comprise the amino acid sequences of SEQ ID NOs: 1, 2, and 3, respectively; and a light chain variable region (V L ) comprising V L CDR1, V L CDR2 and V L CDR3 regions that comprise the amino acid sequences of SEQ ID NOs: 4, 5, and 6, respectively;

(b) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 7; and a light chain variable region comprising amino acid sequence of SEQ ID NO: 8; or

(c) a heavy chain comprising the amino acid sequence of SEQ ID NO: 9; and a light chain comprising amino acid sequence of SEQ ID NO: 10.

7. A vector comprising the nucleic acid molecule of claim 6 .

8. The vector according to claim 7 , further comprising an expression control sequence operably linked to the nucleic acid molecule.

9. A recombinant host cell comprising the vector according to claim 7 .

10. A method for producing a monoclonal antibody or an antigen-binding fragment thereof that specifically binds human OX40R, comprising culturing the isolated host cell of claim 9 under suitable conditions and recovering said antibody or fragment.

11. An isolated nucleic acid molecule comprising a nucleic acid sequence that encodes a heavy chain or an antigen-binding fragment thereof of an antibody that specifically binds human OX40R, wherein said antibody comprises:

(a) a heavy chain variable region (V H ) comprising V H CDR1, V H CDR2 and V H CDR3 regions that comprise the amino acid sequences of SEQ ID NOs: 1, 2, and 3, respectively; and a light chain variable region (V L ) comprising V L CDR1, V L CDR2 and V L CDR3 regions that comprise the amino acid sequences of SEQ ID NOs: 4, 5, and 6, respectively;

(b) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 7; and a light chain variable region comprising amino acid sequence of SEQ ID NO: 8; or

(c) a heavy chain comprising the amino acid sequence of SEQ ID NO: 9; and a light chain comprising amino acid sequence of SEQ ID NO: 10.

12. A vector comprising the nucleic acid molecule of claim 11 .

13. The vector according to claim 12 , further comprising an expression control sequence operably linked to the nucleic acid molecule.

14. A recombinant host cell comprising the vector according to claim 12 .

15. A method for producing a monoclonal antibody or an antigen-binding fragment thereof that specifically binds human OX40R, comprising culturing the isolated host cell of claim 14 under suitable conditions and recovering said antibody or fragment.

16. An isolated nucleic acid molecule comprising a nucleic acid sequence that encodes a light chain or an antigen-binding fragment thereof of an antibody that specifically binds human OX40R, wherein said antibody comprises:

(a) a heavy chain variable region (V H ) comprising V H CDR1, V H CDR2 and V H CDR3 regions that comprise the amino acid sequences of SEQ ID NOs: 1, 2, and 3, respectively; and a light chain variable region (V L ) comprising V L CDR1, V L CDR2 and V L CDR3 regions that comprise the amino acid sequences of SEQ ID NOs: 4, 5, and 6, respectively;

(b) a heavy chain variable region comprising the amino acid sequence of SEQ ID NO: 7; and a light chain variable region comprising amino acid sequence of SEQ ID NO: 8; or

(c) a heavy chain comprising the amino acid sequence of SEQ ID NO: 9; and a light chain comprising amino acid sequence of SEQ ID NO: 10.

17. A vector comprising the nucleic acid molecule of claim 16 .

18. The vector according to claim 17 , further comprising an expression control sequence operably linked to the nucleic acid molecule.

19. A recombinant host cell comprising the vector according to claim 17 .

20. A method for producing a monoclonal antibody or an antigen-binding fragment thereof that specifically binds human OX40R, comprising culturing the isolated host cell of claim 19 under suitable conditions and recovering said antibody or fragment.

21. An isolated nucleic acid molecule, wherein said nucleic acid comprises:

(a) a nucleic acid sequence of SEQ ID NO: 11;

(b) a nucleic acid sequence of SEQ ID NO: 12; or

(c) the nucleic acid sequence of (a) and the nucleic acid sequence of (b).

22. A vector comprising the nucleic acid molecule of claim 21 .

23. The vector according to claim 22 , further comprising an expression control sequence operably linked to the nucleic acid molecule.

24. A recombinant host cell comprising the vector according to claim 22 .

Continuity (5)
Division 13474466 · May 17, 2012
Division 13099196 · May 2, 2011
Division 12332944 · Dec 11, 2008
Provisional Application 61013947 · Dec 14, 2007
Related Publication 20150218279A1 · Aug 6, 2015